Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Impact of mild to moderate renal dysfunction on left ventricular relaxation function and prognosis in ambulatory patients with nonischemic dilated cardiomyopathy.

Ohshima K, Hirashiki A, Cheng XW, Hayashi M, Hayashi D, Okumura T, Sakakibara M, Funahashi H, Ohshima S, Murohara T.

Int Heart J. 2011;52(6):366-71.

2.

[Prognostic relevance of left ventricular diastolic function parameters in dilated cardiomyopathy].

Schannwell CM, Schoebel FC, Marx R, Plehn G, Leschke M, Strauer BE.

Z Kardiol. 2001 Apr;90(4):269-79. German.

PMID:
11381575
3.
4.
6.

Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation.

Kainuma S, Taniguchi K, Toda K, Funatsu T, Kondoh H, Nishino M, Daimon T, Sawa Y.

J Thorac Cardiovasc Surg. 2011 Oct;142(4):783-92. doi: 10.1016/j.jtcvs.2010.11.031. Epub 2011 Mar 12.

7.

Tei-Index in coronary artery disease--validation in patients with overall cardiac and isolated diastolic dysfunction.

Bruch C, Schmermund A, Dagres N, Katz M, Bartel T, Erbel R.

Z Kardiol. 2002 Jun;91(6):472-80. Erratum in: Z Kardiol 2002 Aug;91(8):667.

PMID:
12219695
8.

Short-term systolic and diastolic ventricular performance after surgical ventricular restoration for dilated ischemic cardiomyopathy.

Bové T, Van Belleghem Y, Vandenplas G, Caes F, François K, De Backer J, De Pauw M, Van Nooten G.

Eur J Cardiothorac Surg. 2009 Jun;35(6):995-1003; discussion 1003. doi: 10.1016/j.ejcts.2008.11.007. Epub 2009 Jan 10.

PMID:
19136274
9.

Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy.

Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, Simioniuc A, Gullace M, Ghio S, Enriquez-Sarano M, Temporelli PL.

Heart. 2011 Oct;97(20):1675-80. doi: 10.1136/hrt.2011.225789. Epub 2011 Jul 31.

PMID:
21807656
11.
12.

Loss of adrenergic control of the force-frequency relation in heart failure secondary to idiopathic or ischemic cardiomyopathy.

Bhargava V, Shabetai R, Mathiäsen RA, Dalton N, Hunter JJ, Ross J Jr.

Am J Cardiol. 1998 May 1;81(9):1130-7. Erratum in: Am J Cardiol 1998 Oct 15;82(8):1000.

PMID:
9605055
13.

Dobutamine-induced mechanical alternans is a marker of poor prognosis in idiopathic dilated cardiomyopathy.

Hirashiki A, Izawa H, Cheng XW, Unno K, Ohshima S, Murohara T.

Clin Exp Pharmacol Physiol. 2010 Oct;37(10):1004-9. doi: 10.1111/j.1440-1681.2010.05425.x.

PMID:
20626415
14.

Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy.

Dini FL, Cortigiani L, Baldini U, Boni A, Nuti R, Barsotti L, Micheli G.

Am J Cardiol. 2002 Mar 1;89(5):518-23.

PMID:
11867034
15.

Relationship between renal function, aortic stiffness and left ventricular function in patients with coronary artery disease.

Fukuta H, Ohte N, Mukai S, Asada K, Wakami K, Goto T, Kimura G.

Circ J. 2009 Sep;73(9):1740-5. Epub 2009 Jul 15.

16.

Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT.

Am J Cardiol. 2009 Jan 1;103(1):73-5. doi: 10.1016/j.amjcard.2008.08.045. Epub 2008 Oct 17.

PMID:
19101233
17.

Effects of nitric oxide synthase inhibition on Basal function and the force-frequency relationship in the normal and failing human heart in vivo.

Cotton JM, Kearney MT, MacCarthy PA, Grocott-Mason RM, McClean DR, Heymes C, Richardson PJ, Shah AM.

Circulation. 2001 Nov 6;104(19):2318-23.

18.

The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death.

Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, Beurrier D, Houplon P.

Am J Cardiol. 1997 Jan 15;79(2):154-9.

PMID:
9193015
19.
20.

Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.

Heywood JT, Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN.

Am J Cardiol. 2010 Apr 15;105(8):1140-6. doi: 10.1016/j.amjcard.2009.12.016. Epub 2010 Feb 20.

PMID:
20381667

Supplemental Content

Support Center